| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Radiation Branch, National Cancer Institute, NIH, Bethesda, Maryland
The radiation response of murine L1210 leukemia was examined. Radiation dose-survival curves demonstrated that nondividing (resting) leukemic cells and logarithmically proliferating leukemic cells were equally radiosensitive. A radiosensitive state was also demonstrated for 2 drug-altered leukemia cell lines, 1 strain being markedly resistant to antimetabolite therapy and the other having a decreased growth rate following exposure to an alkylating agent. These studies indicate that cross-resistance does not exist in this experimental system under conditions where drug resistance is present.
Received 6/ 8/66. Accepted 9/ 1/66.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |